Psychiatry and Neurology, Neurology · East Meadow, NY
NPI
1073774725
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1530 Front St Ste 400
East Meadow, NY, 11554
Phone (516) 663-4525
Groups this clinician bills Medicare through
Medicare paid, 2024
$254K
20,932 services
Medicare patients, 2024
653
Average age 76
Drug cost, 2024
$1.5M
3,163 prescriptions
Company payments, 2025
$378
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nora L Chan was code J0585 (injection, onabotulinumtoxina, 1 unit), 9,700 times for 23 patients. In total Nora L Chan billed 20,932 services in 29 codes, and Medicare paid $254K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 9,700 | 23 | $4.97 | $48K |
| J0588 Injection, incobotulinumtoxin a, 1 unit | Office | 6,280 | 28 | $4.11 | $26K |
| J0587 Injection, rimabotulinumtoxinb, 100 units | Office | 3,052 | 22 | $10.19 | $31K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 538 | 429 | $14.13 | $7,603 |
| 99214 Office E&M - Established | Office | 521 | 371 | $104.85 | $55K |
| 99213 Office E&M - Established | Office | 158 | 134 | $71.75 | $11K |
| 99204 Office E&M - New | Office | 148 | 148 | $137.19 | $20K |
| 99215 Office E&M - Established | Office | 93 | 90 | $151.26 | $14K |
| 64611 Musculoskeletal | Office | 66 | 28 | $121.86 | $8,043 |
| 95983 Electrical Nerve Conductivity | Office | 64 | 29 | $42.50 | $2,720 |
| 64616 Musculoskeletal | Office | 56 | 22 | $172.17 | $9,642 |
| 95874 Musculoskeletal | Office | 54 | 30 | $70.35 | $3,799 |
| 64612 Musculoskeletal | Office | 41 | 19 | $148.35 | $6,082 |
| 36415 Venipuncture Blood Collection | Office | 37 | 36 | $8.42 | $311 |
| 95984 Electrical Nerve Conductivity | Office | 29 | 15 | $37.11 | $1,076 |
By year: 2022 $140K for 10,860 services; 2023 $210K for 16,361 services; 2024 $254K for 20,932 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 37 | 36 | $8.42 | $311 |
Medicare prescription drug claims, 2024
In 2024, the drug Nora L Chan prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 740 prescriptions and refills. In total Nora L Chan wrote 3,163 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 740 | 1,851 | 318 | $26K |
| Donepezil Hcl Generic | 189 | 408 | 73 | $1,796 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 185 | 528 | 78 | $7,635 |
| Primidone Generic | 161 | 377 | 57 | $3,923 |
| Rasagiline Mesylate Generic | 136 | 372 | 49 | $36K |
| Gabapentin Generic | 120 | 266 | 45 | $2,002 |
| Amantadine Amantadine Hcl | 105 | 253 | 37 | $13K |
| Memantine Hcl Generic | 95 | 204 | 35 | $3,108 |
| Quetiapine Fumarate Generic | 90 | 184 | 35 | $1,737 |
| Rytary Carbidopa/Levodopa | 87 | 182 | 32 | $173K |
| Clonazepam Generic | 86 | 86 | 27 | $1,129 |
| Neupro Rotigotine | 70 | 135 | 17 | $110K |
| Mirtazapine Generic | 67 | 160 | 21 | $2,041 |
| Propranolol Hcl Generic | 64 | 138 | 26 | $925 |
| Topiramate Generic | 55 | 113 | 21 | $429 |
Brand drugs: 478 claims; generic drugs: 2,685 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nora L Chan $378 ($378 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $66.76.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 2 | $66.76 |
| Merz Pharmaceuticals, LLC | 2 | $60.4 |
| Axsome Therapeutics, Inc. AXSM | 1 | $33.15 |
| Vanda Pharmaceuticals Inc. VNDA | 1 | $32.09 |
| SK Life Science, Inc. | 1 | $27.98 |
| Medtronic, Inc. MDT | 1 | $25.84 |
| Boston Scientific Corporation BSX | 1 | $24.46 |
| MDD US Operations, LLC | 1 | $23.54 |
| Argenx US, Inc. ARGX | 1 | $21.31 |
| Amneal Pharmaceuticals LLC AMRX | 1 | $21.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.